Spectrum's Prior Approval Supplement for Indium-111 ZEVALIN accepted for review by FDA
Links shared publicly online about this topic.
- 419total visits
Spectrum's Prior Approval Supplement for Indium-111 ZEVALIN accepted for review by FDA
Spectrum Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has accepted for review the Prior Approval Supplement containing data providing for the removal of the Indium-111 ZEVALIN® (ibritumomab tiuxetan) pre-treatment imaging evaluation, more commonly referred to as the "bioscan" requirement.
View full resource at news-medical.net
Tags: Diet and Nutrition, Drug, Supplement, Pharma, FDA, Oncology, News
Most Recently Shared on March 23, 2011 at 7:55 am By:
Oncology News: Spectrum's Prior Approval Supplement for Indium-111 ZEVALIN accepted for review by FDA: Spectrum ... http://bit.ly/fsrqm5
Advertisement
